Goyang, South Korea

Sung-Gil Chi

This inventor holds 1 USPTO granted patent. Top assignee: Korea University Research and Business Foundation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung-Gil Chi. Retrieved from https://idiyas.com/inventor/sung-gil-chi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Sung-Gil Chi in Anticancer Research

Introduction

Sung-Gil Chi is a prominent inventor based in Goyang-si, South Korea, known for his groundbreaking work in the field of cancer treatment. With a focus on overcoming drug resistance in cancer cells, Chi has made significant advancements through his innovative approaches.

Latest Patents

Chi holds one notable patent, which is an anticancer prodrug designed to disrupt energy metabolism in cancer cells. His invention comprises a structure featuring a pyruvate dehydrogenase kinase (PDK) inhibitor moiety, a mitochondrial targeting group, and an anthracycline moiety, all reversibly connected. This unique combination aims to effectively combat drug resistance in cancer therapies.

Career Highlights

Sung-Gil Chi is affiliated with the Korea University Research and Business Foundation, where he continues to contribute to research and development in cancer therapeutics. His work reflects a dedication to improving treatment efficacy and patient outcomes in oncology.

Collaborations

Throughout his career, Chi has collaborated with esteemed colleagues such as Jong Seung Kim and Amit Sharma. These partnerships have fostered an environment of innovation and progress in cancer research, enabling the exploration of novel therapeutic strategies.

Conclusion

Sung-Gil Chi's innovative contributions to the field of cancer treatment underscore the importance of research in overcoming the challenges posed by drug resistance. His work exemplifies the potential impact that dedicated inventors can have on medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…